Humanwell Healthcare (group) Co.,ltd. Class ASSE: 600079

Announcement on Jade Silkworm Granules Entering Phase 2 Clinical Trial Study

· Issued by Humanwell Healthcare (group) Co.,ltd. Class A via Shanghai Stock Exchange
Announcement on Jade Silkworm Granules Entering Phase 2 Clinical Trial Study

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment